Aurora Cannabis (ACB) Receivables - Net (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Receivables - Net data on file, last reported at $31.7 million in Q4 2025.

• Receivables - Net for Q4 2025 came in at $31.7 million, down 10.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $31.7 million (down 10.61% YoY), and the FY2025 annual result was $29.6 million, down 12.17% from the prior year.
• Receivables - Net fell to $31.7 million in Q4 2025 per ACB's latest filing, from $34.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $58.0 million in Q1 2021 and troughed at $22.4 million in Q2 2024.
• A 5-year average of $34.3 million and a median of $32.8 million in 2023 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2025: Receivables - Net plunged 47.68% in 2022, then grew 26.13% in 2025.
• A 5-year view of Receivables - Net shows it stood at $39.8 million in 2021, then retreated by 11.43% to $35.2 million in 2022, then fell by 9.63% to $31.8 million in 2023, then increased by 11.4% to $35.4 million in 2024, then decreased by 10.61% to $31.7 million in 2025.
• Business Quant data shows ACB's Receivables - Net at $31.7 million in Q4 2025, $34.0 million in Q3 2025, and $28.2 million in Q2 2025.